For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
Blog
Market-oriented reforms that can save Medicare $100 billion
Since 1970, Medicare spending has grown from 0.7 percent of GDP to 4.0 percent of GDP, and it is projected to grow even further.
Blog
This week in health care policy: October 16–23, 2026
Medical innovation FDA approves several innovative treatments. Last week, the FDA granted accelerated approval to GSK’s Jemperli for certain untreated…
Blog
This week in health care policy: October 8–15, 2026
Innovation watch Merck expects faster production of its personalized cancer vaccine. CEO Rob Davis told CNBC the six-week turnaround for…
Search Posts
Citation
A Conservative Case for Obamacare?
From Thomas P. Miller’s column in National Review: The response of roughly half of the Senate Republicans was to co-sponsor an alternative bill…
Forbes
Labeling Of Genetically Engineered Foods Is A Losing Proposition
As Joe Six-pack munches Fritos and popcorn during the opening games of the NFL season, does he care what variety of corn was used to…
Boston Herald
Mass. biotech reaps Monsanto deal
From Ira Kantor's article in The Boston Herald: Gregory Conko, senior fellow at the Competitive Enterprise Institute in Washington, D.C., and co-author of…
USA Today
FDA rules won’t do much good
Food-borne illnesses kill as many as 3,000 Americans each year, but consumers should not expect new Food and Drug Administration regulations to help. These rules,…
Real Clear Policy
More FDA Control Does Not Mean More Safety
News outlets are reporting that the U.S. Food and Drug Administration (FDA) has cited an alarmingly high number of alleged safety and regulatory violations by…
Blog
FDA Delay Likely Killed Thousands, Imposed Billions In Costs
The FDA didn’t approve a home test for HIV until 24 years after it first received an application. According to an FDA advisory committee,…
